Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization

A Phase I trial conducted in 2009–2010 demonstrated that oral vaccination with a replication competent Ad4-H5 (A/Vietnam) vector with dosages ranging from 10(7)-10(11) viral particles was well tolerated. HA-specific T-cell responses were efficiently induced, but very limited hemagglutination-inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Khurana, Surender, Coyle, Elizabeth M., Manischewitz, Jody, King, Lisa R., Ishioka, Glenn, Alexander, Jeff, Smith, Jon, Gurwith, Marc, Golding, Hana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309450/
https://www.ncbi.nlm.nih.gov/pubmed/25629161
http://dx.doi.org/10.1371/journal.pone.0115476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309450/
https://www.ncbi.nlm.nih.gov/pubmed/25629161
http://dx.doi.org/10.1371/journal.pone.0115476

Ejemplares similares